Congratulations to Drs. Bette Caan, Elizabeth Feliciano, and the Kaiser Permanente Northern California (KPNC) CANCAN team, for achieving a significant milestone in patient recruitment. The Kaiser study has successfully recruited over 400 patients for their cachexia clinical observational study. This CANCAN patient study aims to identify different patient subtypes of cancer cachexia. Cheers to the Kaiser team and keep up the outstanding work!







